Insider · CIK 0001852129

Callos Andrew

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001852129

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+10K sh	$23.26	+$233K	68,555
2026-08-31	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−10K sh	$70.24	−$702K	58,555
2026-08-31	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−10K sh	—	—	0
2026-07-30	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+14K sh	$23.26	+$326K	72,555
2026-07-30	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−14K sh	$79.88	−$1.12M	58,555
2026-07-30	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−14K sh	—	—	10,000
2026-07-01	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+15K sh	$23.26	+$349K	73,555
2026-07-01	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−15K sh	$85.80	−$1.29M	58,555
2026-07-01	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−15K sh	—	—	24,000
2026-06-01	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+15K sh	$23.26	+$349K	73,555
2026-06-01	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−15K sh	$74.08	−$1.11M	58,555
2026-06-01	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−15K sh	—	—	39,000
2026-05-05	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+11.3K sh	$39.13	+$443K	69,888
2026-05-05	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−11.3K sh	$77.25	−$875K	58,555
2026-05-05	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−11.3K sh	—	—	13,070
2026-05-01	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+15.9K sh	$37.63	+$597K	74,412
2026-05-01	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−15.9K sh	$65.00	−$1.03M	58,555
2026-05-01	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−15.9K sh	—	—	0
2026-04-30	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+15K sh	$23.26	+$349K	73,555
2026-04-30	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−15K sh	$63.26	−$949K	58,555
2026-04-30	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−15K sh	—	—	54,000
2026-04-15	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−7,449 sh	$66.02	−$492K	58,555
2026-03-31	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−3,639 sh	$65.00	−$237K	66,004
2026-03-18	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−1,930 sh	$62.07	−$120K	78,185
2026-03-17	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−5,626 sh	$62.15	−$350K	74,489
2026-03-17	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−2,916 sh	$62.15	−$181K	71,573
2026-03-16	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−1,709 sh	$61.03	−$104K	46,149
2026-03-15	CYTKCYTOKINETICS INCA Award	EVP, Chief Commercial Officer	AAward	+20.6K sh	—	—	68,504
2026-03-15	CYTKCYTOKINETICS INCA Award	EVP, Chief Commercial Officer	AAward	+13.3K sh	—	—	81,824
2026-03-15	CYTKCYTOKINETICS INC · Incentive Stock Option (Right to Buy)A Award	EVP, Chief Commercial Officer	AAward	+1,665 sh	—	—	1,665
2026-03-15	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)A Award	EVP, Chief Commercial Officer	AAward	+29.5K sh	—	—	29,480
2026-03-09	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−2,582 sh	$60.72	−$157K	47,858
2026-03-05	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+11K sh	$39.13	+$430K	76,440
2026-03-05	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−15K sh	$61.87	−$928K	61,440
2026-03-05	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−11K sh	$61.88	−$681K	50,440
2026-03-05	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+15K sh	$23.26	+$349K	65,440
2026-03-05	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−11K sh	—	—	24,403
2026-03-05	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−15K sh	—	—	69,000
2026-03-02	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+886 sh	$37.63	+$33.3K	51,326
2026-03-02	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−886 sh	$61.62	−$54.6K	50,440
2026-03-02	CYTKCYTOKINETICS INC · Incentive Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−886 sh	—	—	0
2026-02-05	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+15K sh	$23.26	+$349K	65,440
2026-02-05	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−15K sh	$61.93	−$929K	50,440
2026-02-05	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−15K sh	—	—	84,000
2026-02-02	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+886 sh	$37.63	+$33.3K	51,326
2026-02-02	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−886 sh	$62.10	−$55K	50,440
2026-02-02	CYTKCYTOKINETICS INC · Incentive Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−886 sh	—	—	886
2026-01-05	CYTKCYTOKINETICS INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+15K sh	$23.26	+$349K	65,440
2026-01-05	CYTKCYTOKINETICS INCS Sale	EVP, Chief Commercial Officer	SSale	−15K sh	$60.28	−$904K	50,440
2026-01-05	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−15K sh	—	—	99,000

Recent filings

Accepted (ET)
Aug 314
Callos Andrew0001061983-26-000090
SEC(opens sec.gov)
Jul 304
Callos Andrew0001061983-26-000086
SEC(opens sec.gov)
Jul 24
Callos Andrew0001061983-26-000073
SEC(opens sec.gov)
Jun 14
Callos Andrew0001061983-26-000065
SEC(opens sec.gov)
May 54
Callos Andrew0001061983-26-000047
SEC(opens sec.gov)
May 44
Callos Andrew0001061983-26-000046
SEC(opens sec.gov)
Apr 304
Callos Andrew0001061983-26-000045
SEC(opens sec.gov)

Companies

CYTOKINETICS INCEVP, Chief Commercial OfficerCYTK

Address

SOUTH SAN FRANCISCO, CA, 94080